SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-20-008254
Filing Date
2020-07-14
Accepted
2020-07-14 16:40:56
Documents
2
Period of Report
2020-07-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 5187
2 POWER OF ATTORNEY ex24poa.txt EX-24.POA 2909
  Complete submission text file 0001179110-20-008254.txt   9645
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Issuer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ARTARA THERAPEUTICS, INC. 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address
Marshall Randall (Reporting) CIK: 0001799325 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36694 | Film No.: 201027461